美罗华在淋巴瘤治疗中的应用课件.pptVIP

Usually quite a bit of text goes here. Author FM. Journal year;vol:pp–pp. Fifty seven patients were evaluable for response.1 Among those, 40% (23 patients) achieved a response with their second course of rituximab, indicating that retreatment with rituximab is effective in a percentage of patients. Six patients achieved complete responses (11%). 1Davis TA, Grillo-Lopez AJ, White CA, et al. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkins lymphoma: safety and efficacy of re-treatment. J Clin Oncol 2000; 18:3135-43. Usually quite a bit of text goes here. Author FM